Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ocuphire Pharma, Inc. | Director | Common Stock | 132K | $233K | $1.77 | Jun 11, 2024 | Direct |
Ocuphire Pharma, Inc. | Director | Stock Option (Right to Buy) | 35.2K | Jun 11, 2024 | Direct | ||
Kintara Therapeutics, Inc. | Director | Options (Right to Buy) | 13.6K | Oct 18, 2024 | Direct | ||
Kintara Therapeutics, Inc. | Director | Common Stock | 0 | Oct 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KTRA | Kintara Therapeutics, Inc. | Oct 18, 2024 | 2 | $0 | 4 | Oct 22, 2024 | Director |
KTRA | Kintara Therapeutics, Inc. | Oct 18, 2024 | 0 | $0 | 3 | Oct 22, 2024 | Director |
OCUP | Ocuphire Pharma, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 13, 2024 | Director |
OCUP | Ocuphire Pharma, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Director |
OCUP | Ocuphire Pharma, Inc. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
OCUP | Ocuphire Pharma, Inc. | Apr 19, 2023 | 1 | $0 | 4 | Apr 21, 2023 | Director |
OCUP | Ocuphire Pharma, Inc. | Jan 11, 2023 | 1 | $0 | 4 | Jan 12, 2023 | Director |
OCUP | Ocuphire Pharma, Inc. | Oct 11, 2022 | 2 | $0.08 | 4 | Oct 12, 2022 | Director |
OCUP | Ocuphire Pharma, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director |
OCUP | Ocuphire Pharma, Inc. | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
OCUP | Ocuphire Pharma, Inc. | May 20, 2022 | 1 | $9.95K | 4 | May 24, 2022 | Director |
OCUP | Ocuphire Pharma, Inc. | Nov 18, 2021 | 1 | $7K | 4 | Nov 22, 2021 | Director |
OCUP | Ocuphire Pharma, Inc. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |